Logo image of OPK

OPKO HEALTH INC (OPK) Stock Fundamental Analysis

NASDAQ:OPK - Nasdaq - US68375N1037 - Common Stock - Currency: USD

1.33  0 (0%)

After market: 1.33 0 (0%)

Fundamental Rating

2

Taking everything into account, OPK scores 2 out of 10 in our fundamental rating. OPK was compared to 102 industry peers in the Health Care Providers & Services industry. While OPK seems to be doing ok healthwise, there are quite some concerns on its profitability. OPK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year OPK has reported negative net income.
OPK had a negative operating cash flow in the past year.
OPK had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: OPK reported negative operating cash flow in multiple years.
OPK Yearly Net Income VS EBIT VS OCF VS FCFOPK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.83%, OPK is in line with its industry, outperforming 43.14% of the companies in the same industry.
OPK has a Return On Equity (-2.97%) which is in line with its industry peers.
Industry RankSector Rank
ROA -1.83%
ROE -2.97%
ROIC N/A
ROA(3y)-8.99%
ROA(5y)-5.4%
ROE(3y)-12.84%
ROE(5y)-7.7%
ROIC(3y)N/A
ROIC(5y)N/A
OPK Yearly ROA, ROE, ROICOPK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

The Gross Margin of OPK (31.78%) is comparable to the rest of the industry.
OPK's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for OPK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.21%
GM growth 5Y-3.46%
OPK Yearly Profit, Operating, Gross MarginsOPK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

5

2. Health

2.1 Basic Checks

OPK does not have a ROIC to compare to the WACC, probably because it is not profitable.
OPK has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, OPK has more shares outstanding
OPK has a worse debt/assets ratio than last year.
OPK Yearly Shares OutstandingOPK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
OPK Yearly Total Debt VS Total AssetsOPK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

OPK has an Altman-Z score of -0.47. This is a bad value and indicates that OPK is not financially healthy and even has some risk of bankruptcy.
OPK has a worse Altman-Z score (-0.47) than 80.39% of its industry peers.
OPK has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.25, OPK is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z -0.47
ROIC/WACCN/A
WACC8.28%
OPK Yearly LT Debt VS Equity VS FCFOPK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.49 indicates that OPK has no problem at all paying its short term obligations.
The Current ratio of OPK (2.49) is better than 85.29% of its industry peers.
OPK has a Quick Ratio of 2.28. This indicates that OPK is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of OPK (2.28) is better than 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 2.49
Quick Ratio 2.28
OPK Yearly Current Assets VS Current LiabilitesOPK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

3

3. Growth

3.1 Past

OPK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.10%, which is quite impressive.
Looking at the last year, OPK shows a very negative growth in Revenue. The Revenue has decreased by -13.78% in the last year.
OPK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.59% yearly.
EPS 1Y (TTM)45.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
Revenue 1Y (TTM)-13.78%
Revenue growth 3Y-26.21%
Revenue growth 5Y-4.59%
Sales Q2Q%-13.7%

3.2 Future

The Earnings Per Share is expected to grow by 13.73% on average over the next years. This is quite good.
The Revenue is expected to grow by 7.02% on average over the next years.
EPS Next Y-71.77%
EPS Next 2Y-4.19%
EPS Next 3Y13.73%
EPS Next 5YN/A
Revenue Next Year-4.76%
Revenue Next 2Y1.33%
Revenue Next 3Y5.25%
Revenue Next 5Y7.02%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OPK Yearly Revenue VS EstimatesOPK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
OPK Yearly EPS VS EstimatesOPK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.1 -0.2 -0.3 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

OPK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year OPK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OPK Price Earnings VS Forward Price EarningsOPK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OPK Per share dataOPK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as OPK's earnings are expected to grow with 13.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.19%
EPS Next 3Y13.73%

More info and screens

0

5. Dividend

5.1 Amount

OPK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OPKO HEALTH INC

NASDAQ:OPK (6/16/2025, 6:40:46 PM)

After market: 1.33 0 (0%)

1.33

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners31.1%
Inst Owner Change23.14%
Ins Owners5.17%
Ins Owner Change0%
Market Cap1.05B
Analysts83.64
Price Target3.15 (136.84%)
Short Float %8.07%
Short Ratio9.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)33.11%
Min EPS beat(2)-44.39%
Max EPS beat(2)110.61%
EPS beat(4)3
Avg EPS beat(4)40.08%
Min EPS beat(4)-44.39%
Max EPS beat(4)110.61%
EPS beat(8)4
Avg EPS beat(8)23.63%
EPS beat(12)6
Avg EPS beat(12)-132.93%
EPS beat(16)7
Avg EPS beat(16)-133.51%
Revenue beat(2)1
Avg Revenue beat(2)3.66%
Min Revenue beat(2)-9.64%
Max Revenue beat(2)16.97%
Revenue beat(4)1
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-9.64%
Max Revenue beat(4)16.97%
Revenue beat(8)4
Avg Revenue beat(8)3.26%
Revenue beat(12)6
Avg Revenue beat(12)3.97%
Revenue beat(16)8
Avg Revenue beat(16)5.53%
PT rev (1m)-22.59%
PT rev (3m)-21.94%
EPS NQ rev (1m)3.8%
EPS NQ rev (3m)-41.61%
EPS NY rev (1m)0%
EPS NY rev (3m)-21.75%
Revenue NQ rev (1m)-0.27%
Revenue NQ rev (3m)-1.66%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-5.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.53
P/FCF N/A
P/OCF N/A
P/B 0.8
P/tB 14.76
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0.87
BVpS1.65
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.83%
ROE -2.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.78%
FCFM N/A
ROA(3y)-8.99%
ROA(5y)-5.4%
ROE(3y)-12.84%
ROE(5y)-7.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.21%
GM growth 5Y-3.46%
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 24.79%
Cap/Sales 3.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.49
Quick Ratio 2.28
Altman-Z -0.47
F-Score4
WACC8.28%
ROIC/WACCN/A
Cap/Depr(3y)21.19%
Cap/Depr(5y)28.79%
Cap/Sales(3y)2.61%
Cap/Sales(5y)2.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
EPS Next Y-71.77%
EPS Next 2Y-4.19%
EPS Next 3Y13.73%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.78%
Revenue growth 3Y-26.21%
Revenue growth 5Y-4.59%
Sales Q2Q%-13.7%
Revenue Next Year-4.76%
Revenue Next 2Y1.33%
Revenue Next 3Y5.25%
Revenue Next 5Y7.02%
EBIT growth 1Y-36.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.13%
EBIT Next 3Y32.69%
EBIT Next 5Y26.34%
FCF growth 1Y-71.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-86.39%
OCF growth 3YN/A
OCF growth 5YN/A